Matches in SemOpenAlex for { <https://semopenalex.org/work/W2984773385> ?p ?o ?g. }
- W2984773385 endingPage "582" @default.
- W2984773385 startingPage "582" @default.
- W2984773385 abstract "Multifunctional nanomedicines with active targeting and stimuli-responsive drug release function utilizing pathophysiological features of the disease are regarded as an effective strategy for treatment of rheumatoid arthritis (RA). Under the inflammatory environment of RA, activated macrophages revealed increased expression of folate receptor and elevated intracellular reactive oxygen species (ROS) level. In this study, we successfully conjugated folate to polyethylene glycol 100 monostearate as film-forming material and further prepared methotrexate (MTX) and catalase (CAT) co-encapsulated liposomes, herein, shortened to FOL-MTX&CAT-L, that could actively target to activated macrophages. Thereafter, elevated intracellular hydrogen peroxide, the main source of ROS, diffused into liposomes and encapsulated CAT catalyzed the decomposition of hydrogen peroxide into oxygen and water. Continuous oxygen-generation inside liposomes would eventually disorganize its structure and release the encapsulated MTX. We characterized the in vitro drug release, cellular uptake and cytotoxicity studies as well as in vivo pharmacokinetics, biodistribution, therapeutic efficacy and safety studies of FOL-MTX&CAT-L. In vitro results revealed that FOL-MTX&CAT-L possessed sufficient ROS-sensitive drug release, displayed an improved cellular uptake through folate-mediated endocytosis and exhibited a higher cytotoxic effect on activated RAW264.7 cells. Moreover, in vivo results showed prolonged blood circulation time of PEGylated liposomes, enhanced accumulation of MTX in inflamed joints of collagen-induced arthritis (CIA) mice, reinforced therapeutic efficacy and minimal toxicity toward major organs. These results imply that FOL-MTX&CAT-L may be used as an effective nanomedicine system for RA treatment." @default.
- W2984773385 created "2019-11-22" @default.
- W2984773385 creator A5006141258 @default.
- W2984773385 creator A5011555649 @default.
- W2984773385 creator A5014131230 @default.
- W2984773385 creator A5028954622 @default.
- W2984773385 creator A5030572474 @default.
- W2984773385 creator A5057100472 @default.
- W2984773385 creator A5074551305 @default.
- W2984773385 date "2019-11-06" @default.
- W2984773385 modified "2023-10-15" @default.
- W2984773385 title "Folate Receptor-Targeting and Reactive Oxygen Species-Responsive Liposomal Formulation of Methotrexate for Treatment of Rheumatoid Arthritis" @default.
- W2984773385 cites W1584738578 @default.
- W2984773385 cites W1750338110 @default.
- W2984773385 cites W1764042517 @default.
- W2984773385 cites W1964016270 @default.
- W2984773385 cites W1974276156 @default.
- W2984773385 cites W1977678718 @default.
- W2984773385 cites W1983172235 @default.
- W2984773385 cites W1986336802 @default.
- W2984773385 cites W1996498972 @default.
- W2984773385 cites W2000676357 @default.
- W2984773385 cites W2001213139 @default.
- W2984773385 cites W2009805303 @default.
- W2984773385 cites W2015238187 @default.
- W2984773385 cites W2018320089 @default.
- W2984773385 cites W2021787005 @default.
- W2984773385 cites W2021911135 @default.
- W2984773385 cites W2030234149 @default.
- W2984773385 cites W2031261733 @default.
- W2984773385 cites W2033423092 @default.
- W2984773385 cites W2038484123 @default.
- W2984773385 cites W2040149576 @default.
- W2984773385 cites W2040379624 @default.
- W2984773385 cites W2040990783 @default.
- W2984773385 cites W2044414574 @default.
- W2984773385 cites W2048701418 @default.
- W2984773385 cites W2049592726 @default.
- W2984773385 cites W2052028900 @default.
- W2984773385 cites W2053120383 @default.
- W2984773385 cites W2056644518 @default.
- W2984773385 cites W2059462453 @default.
- W2984773385 cites W2067068975 @default.
- W2984773385 cites W2068702139 @default.
- W2984773385 cites W2069206441 @default.
- W2984773385 cites W2075124697 @default.
- W2984773385 cites W2079082252 @default.
- W2984773385 cites W2081829590 @default.
- W2984773385 cites W2083628264 @default.
- W2984773385 cites W2094948182 @default.
- W2984773385 cites W2095187713 @default.
- W2984773385 cites W2104861305 @default.
- W2984773385 cites W2111668932 @default.
- W2984773385 cites W2111834556 @default.
- W2984773385 cites W2122917464 @default.
- W2984773385 cites W2138811102 @default.
- W2984773385 cites W2139975712 @default.
- W2984773385 cites W2146607274 @default.
- W2984773385 cites W2150451572 @default.
- W2984773385 cites W2162495360 @default.
- W2984773385 cites W2171529323 @default.
- W2984773385 cites W2171979139 @default.
- W2984773385 cites W2207471679 @default.
- W2984773385 cites W2262569991 @default.
- W2984773385 cites W2280162925 @default.
- W2984773385 cites W2284469734 @default.
- W2984773385 cites W2290811327 @default.
- W2984773385 cites W2298332245 @default.
- W2984773385 cites W2313462881 @default.
- W2984773385 cites W2324605147 @default.
- W2984773385 cites W2333550032 @default.
- W2984773385 cites W2416499453 @default.
- W2984773385 cites W2471463846 @default.
- W2984773385 cites W2478714140 @default.
- W2984773385 cites W2515724475 @default.
- W2984773385 cites W2517644704 @default.
- W2984773385 cites W2547309843 @default.
- W2984773385 cites W2558722500 @default.
- W2984773385 cites W2588763772 @default.
- W2984773385 cites W2591989059 @default.
- W2984773385 cites W2593333911 @default.
- W2984773385 cites W2623617647 @default.
- W2984773385 cites W2735787983 @default.
- W2984773385 cites W2756440148 @default.
- W2984773385 cites W2790454653 @default.
- W2984773385 cites W2799375964 @default.
- W2984773385 cites W2884237997 @default.
- W2984773385 cites W2884431837 @default.
- W2984773385 cites W2891474673 @default.
- W2984773385 cites W2895757261 @default.
- W2984773385 cites W2917189517 @default.
- W2984773385 cites W2920324197 @default.
- W2984773385 cites W334564628 @default.
- W2984773385 cites W38682668 @default.
- W2984773385 cites W4361867558 @default.
- W2984773385 cites W927490578 @default.
- W2984773385 doi "https://doi.org/10.3390/pharmaceutics11110582" @default.
- W2984773385 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6921073" @default.